List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.2.4 Integrase inhibitors |
Others observations: For use in pregnant women and in second-line regimens in accordance with WHO treatment guidelines. |
PAHO Strategic Fund Medicine List | 2.6.1. Antiretrovirals | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.2.4 Integrase inhibitors |
Others observations: For use in pregnant women and in second-line regimens in accordance with WHO treatment guidelines. |
PAHO Strategic Fund Medicine List | 2.6.1. Antiretrovirals | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.2.4 Integrase inhibitors |
Others observations: For use in pregnant women and in second-line regimens in accordance with WHO treatment guidelines. |
PAHO Strategic Fund Medicine List | 2.6.1. Antiretrovirals | No observations |
List | Section | Observation |
---|---|---|
PAHO Strategic Fund Medicine List | 2.6.1. Antiretrovirals | No observations |